Wang Ru-Xiang, Boland Greet J, van Hattum Jan, de Gast Gijsbert C
Shenyang Center for Disease Control and Prevention, Shenyang 110031, Liaoning Province, China.
World J Gastroenterol. 2004 Jan 15;10(2):260-3. doi: 10.3748/wjg.v10.i2.260.
To determine if the T cell memory to HBsAg can persist for a long time after hepatitis B (HB) vaccination.
Thirty one vaccine recipients who were healthcare workers (18 females and 13 males aged 34-58 years) from Utrecht University Hospital, Netherlands, and had previously received a standard course of vaccination for hepatitis B were investigated and another 9 unvaccinated healthy volunteers from the same hospital were used as the control. Blood samples were taken just before the experiment to test serum anti-HBs levels and the subjects were classified into different groups according to their serum titers of anti-HBs and vaccination history. Their peripheral blood mononuclear cells (PBMC) were isolated from freshly heparinized venous blood and the proliferative response of T lymphocytes to the recombinant hepatitis B surface antigen (HBsAg) was investigated.
Positive serum anti-HBs was found in 61.3% (19/31) vaccine recipients and a significant in vitro lymphocyte proliferative response to recombinant HBsAg was observed in all the vaccinees with positive anti-HBs. Serum anti-HBs level < or =10 IU/L was found in 38.7% (12/31) subjects. In this study, we specially focused on lymphocyte proliferative response to recombinant HBsAg in those vaccine recipients with serum anti-HBsAg less than 10 IU/L. Most of them had received a standard course of vaccination about 10 years before. T lymphocyte proliferative response was found positive in 7 of the 12 vaccine recipients. These results confirmed that HBsAg-specific memory T cells remained detectable in the circulation for a long time after vaccination, even when serum anti-HBs level had been undetectable.
The T cell memory to HBsAg can persist for at least 10 years after HB vaccination. Further booster injection is not necessary in healthy responders to HB vaccine.
确定乙肝(HB)疫苗接种后针对乙肝表面抗原(HBsAg)的T细胞记忆能否长期持续存在。
对来自荷兰乌得勒支大学医院的31名医护人员疫苗接种者(18名女性和13名男性,年龄34 - 58岁)进行研究,这些人之前已接受过标准疗程的乙肝疫苗接种,另选取同一医院9名未接种疫苗的健康志愿者作为对照。在实验前采集血样检测血清抗-HBs水平,并根据抗-HBs血清滴度和疫苗接种史将受试者分为不同组。从新鲜肝素化静脉血中分离出外周血单个核细胞(PBMC),研究T淋巴细胞对重组乙肝表面抗原(HBsAg)的增殖反应。
在31名疫苗接种者中,61.3%(19/31)血清抗-HBs呈阳性,在所有抗-HBs阳性的疫苗接种者中均观察到对重组HBsAg有显著的体外淋巴细胞增殖反应。38.7%(12/31)的受试者血清抗-HBs水平≤10 IU/L。在本研究中,我们特别关注血清抗-HBsAg低于10 IU/L的那些疫苗接种者对重组HBsAg的淋巴细胞增殖反应。他们大多数在约10年前接受过标准疗程的疫苗接种。12名疫苗接种者中有7名T淋巴细胞增殖反应呈阳性。这些结果证实,即使血清抗-HBs水平已检测不到,接种疫苗后针对HBsAg的特异性记忆T细胞仍能在循环中长时间被检测到。
乙肝疫苗接种后针对HBsAg的T细胞记忆至少可持续10年。对于乙肝疫苗接种反应良好的健康人群,无需进一步加强注射。